Transforming growth factor-β1 is an autocrine mediator of U937 cell growth arrest and differentiation induced by vitamin D3 and retinoids

Journal of Cellular Physiology

Volumn 178, Issue 1, 1999, Pages 109-119

  Defacque, Hélène ^a   Piquemal, David ^b   Basset, Annie ^b   Marti, Jacques ^b   Commes, Thérèse ^b  

^a EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COLECALCIFEROL; NEUTRALIZING ANTIBODY; RETINOID; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; AUTOCRINE EFFECT; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOMODULATION; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 3743126193     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4652(199901)178:1<109::AID-JCP14>3.0.CO;2-X     Document Type: Article

References (34)

1. Abe M, Harpel JG, Metz CN, Nunes L, Loskutoff DJ, Rifkin DB. 1994. An assay for transforming growth factor-β using cells transfected with a plasminogen activator inhibitor-1 promoter luciferase construct. Anal Biochem 216:276-284.
2. Assoian RK, Fleurdelys BE, Stevenson HC, Miller PJ, Madtes DK, Raines EW, Ross R., Sporn MB. 1987. Expression and secretion of TGFβ by activated human macrophages. Proc Natl Acad Sci U S A 84:6020-6024.
3. Bombara C, Ignotz RA. 1992. TGF-beta inhibits proliferation and promotes differentiation of human promonocytic leukemia cells. J Cell Physiol 153:30-37.
4. Brandes ME, Wakefield LM, Wahl SM. 1991. Modulation of monocyte type I transforming growth factor-β receptors by inflammatory stimuli. J Biol Chem 266:19697-19703.
5. Carlberg C. 1996. The vitamin D3 receptor in the context of the nuclear receptor superfamily. Endocrine 4:91-105.
6. Danielpour D. 1996. Induction of transforming growth factor-β autocrine activity by all-trans-retinoic acid and 1α,25-dihydroxyvitamin D3 in NPR-152 rat prostatic epithelial cells. J Cell Physiol 166:231-239.
7. Defacque H, Commes T, Contet V, Sevilla C, Marti J. 1995. Differentiation of U937 myelomonocytic cell line by all-trans retinoic acid and 1.25-dihydroxyvitamin D3: synergistic effects on tissue transglutaminase. Leukemia 9:1762-1767.
8. Defacque H, Sevilla C, Piquemal D, Rochette-Egly C, Marti J, Commes T. 1997. Potentiation of VD-induced monocytic leukemia cell differentiation by retinoids involves both RAR and RXR signaling pathways. Leukemia 11:221-227.
9. Derynck R, Jarrett JA, Chen EY, Eaton DH, Bell JR, Assoian RK, Roberts AB, Sporn MB, Goeddel DV. 1985. Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells. Nature 316:701-705.
10. Dijke PT, Miyazono K, Heldin C. 1996. Signaling via hetero-oligomeric complexes of type I and II serine/threonine kinase receptors. Curr Opin Cell Biol 8:139-145.
11. Falk LA, De Benedetti F, Lorhey N, Birchenall-Roberts MC, Ellingsworth LW, Faltynek CR, Ruscetti FW. 1991. Induction of trans forming growth factor-β1 receptor expression and TGF-β1 protein production in retinoic acid-treated HL-60 cells: possible TGF-β1-mediated autocrine inhibition. Blood 77:1248-1255.
12. Franzen P, Ten Dijke P, Ichijo H, Yamashita H, Schulz P, Heldin C, Miyazono K. 1993. Cloning of a TGFβ type I receptor that forms a heteromeric complex with the TGFβ type II receptor. Cell 75:681-692.
13. Herbert YL, Wang X, Ng-Eaton E, Weinberg RA, Lodish HF. 1992. Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase. Cell 88:775-785.
14. Kim SJ, Park K, Koeller D, Kim KY, Wakefield LM, Sporn MB, and Roberts AB. 1992. Post-transcriptional regulation of the human transforming growth factor-β1 gene. J Biol Chem 267:13702-13707.
15. Kojima S, Nara K, Rifkin DB. 1993. Requirement for transglutaminase in the activation of latent transforming growth factor-β in bovine endothelial cells. J Cell Biol 121:439-448.
16. Koli K, Keski-Oja J. 1993. Vitamin D3 and calcipotriol enhance the secretion of transforming growth factor-beta1 and -beta2 in cultured murine keratinocytes. Growth Factors 8:153-163.
17. Koli K, Keski-Oja J. 1996. Transforming growth factor-β system and its regulation by members of the steroid-thyroid hormone super family. Cancer Res 70:63-94.
18. Lastres P, Letamendia A, Zhang H, Rius C, Almendro N, Raab U, Lopez LA, Fabra A, Letarte M, Bernabeu C. 1996. Endoglin modulates cellular responses to TGF-beta1. J Cell Biol 133:1109-1121.
19. Liu M, Lee MH, Cohen M, Bommakanti M, Freedman LP. 1996a. Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. Gene Dev 10:142-153.
20. WAF1/CIP1 gene by retinoic acid receptor. J Biol Chem 49:31723-31728.
21. Lorand L, Conrad SM. 1984. Transglutaminases. Mol Cell Biochem 58:9-35.
22. Mangelsdorf DJ, Umesono K, Evans RM. 1994. The retinoid receptors. In: The retinoids: biology, chemistry and medicine. Raven Press: New York. 319-349.
23. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schütz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans R. 1995. The nuclear receptor superfamily: the second decade. Cell 83:835-839.
24. Marti J, Commes T, Defacque H, Sevilla C. 1997. Vitamin D and 9-cis retinoic acid: an efficient partnership for the induction of myelomonocytic cell growth inhibition and differentiation. Leuk Res 21:173-176.
25. Mercier T, Chaumontet C, Gaillard-Sanchez I, Martel P, Hederden C. 1996a. Calcitriol and lexicalcitol (KH1060) inhibit the growth of human breast adenocarcinoma cells by enhancing transforming growth factor-β production. Biochem Pharmacol 52:505-510.
26. Mercier T, Gaillard-Sanchez I, Martel P, Heberden C. 1996b. TGF-β receptors are diminished after retinoid exposure in rat liver epithelial cells. J Cell Biochem 61:230-237.
27. Nunes I, Kojima S, Rifkin DB. 1996a. Effects of endogenously activated transforming growth factor-β on growth and differentiation of retinoic acid-treated HL-60 cells. Cancer Res 56:495-499.
28. Nunes I, Munger JS, Harpel JG, Nagano Y, Shapiro RL, Gleizes PE, Rifkin DB. 1996b. Structure and activation of the large latent transforming growth factor-β complex. Int J Obes 20:4-8.
29. Polyak K. 1996. Negative regulation of cell growth by TGF-β. Biochem Biophys Acta 1242:185-199.
30. Roberts AB, Sporn MB. 1992. Mechanistic interrelationships between two super-families: the steroid/retinoid receptors and TGFβ. Cancer Surv 14:205-220.
31. Romeo DS, Park K, Roberts AB, Kim SJ. 1993. An element of the transforming growth factor-beta1, 5′-untranslated region represses translation and specifically binds a cytosolic factor. Mol Endocrinol 7:759-766.
32. Taipale J, Matikainen S, Hurme M, Keski-Oja J. 1994. Induction of transforming growth factor β1 and its receptor expression during myeloid leukemia cell differentiation. Cell Growth Differ 5:1309-1319.
33. Testa U, Masciulli R, Trirarelli E, Pustorino R, Mariani G, Martucci R, Barberi T, Camagna A, Valtieri M, Peschle C. 1993. Transforming growth factor-β potentiates vitamin D3-induced terminal monocytic differentiation of human leukemic cell lines. J Immunol 150: 2418-2430.
34. Turley JM, Falk LA, Ruscetti WF, Kasper JJ, Francomano T, Fu T, Bang OS, Birchenall-Roberts MC. 1996. Transforming growth factor-β1 functions in monocytic differentiation of hematopoietic cells through autocrine and paracrine mechanisms. Cell Growth Differ 7:1535-1544.